menu search

Ms-13 murder suspect released into u.s. as an unaccompanied alien child

Washington, D.C., Jan. 23, 2023 (GLOBE NEWSWIRE) — Washington, D.C. (January 23, 2023) –The Center for Immigration ...

January 23, 2023, 8:33 pm

Revive therapeutics submits updated briefing package to fda for covid treatment

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) told investors that it has submitted its updated briefing package to the US Food and Drug Administrati...

January 20, 2023, 6:32 am

Poptential™ free american history curriculum highlights legacy of african americans for black history month

INDIANAPOLIS, Jan. 17, 2023 (GLOBE NEWSWIRE) — Certell’s Poptential™, a family of free, award-winning social ...

January 17, 2023, 11:30 am

Imf report on warns that fragmentation of global economy could see -7% hit to global gdp

An IMF reports says:

  • even as we need more international cooperation on multiple fronts, we are facing the specter of a new Cold War that...

    January 16, 2023, 11:14 pm

Immigration policy in the courts

What Happened in 2022, What’s Coming in 2023 Washington, D.C., Jan. 13, 2023 (GLOBE NEWSWIRE) — A new report by the Center for Immigration ...

January 13, 2023, 3:30 pm

Eur/usd: bulls hold grip but correction may precede fresh advance

The Euro is consolidating under new multi-month high on Friday, after advancing 0.9% on Thursday. Overall picture remains bullish as the pair is on tr...

January 13, 2023, 12:01 pm

Verona pharma: breathing deeply could bring great benefits

Verona Pharma is a biopharmaceutical company involved in studies and product development related to res...

January 13, 2023, 2:31 am

Eur/usd: euro keeps bullish stance but us cpi data likely to define near-term direction

The Euro keeps bullish bias in early Wednesday and regains traction after bulls took a breather (Tuesday’s Doji). Full reversal of January’s pullb...

January 11, 2023, 8:43 am

Algernon pharmaceuticals appoints cough study expert dr peter dicpinigaitis as medical advisor

Algernon Pharmaceuticals Inc told investors that Dr Peter Dicpinigaitis, regarded as an authority on clinical ...

January 11, 2023, 7:52 am

Aud/usd outlook: break of key barriers signals further advance

Daily studies remain in full bullish setup, with additional positive signals seen from weekly close abo...

January 9, 2023, 8:59 am

Biden’s unconstitutional border plan: the funneling of illegal migrants into the us

Washington, D.C., Jan. 06, 2023 (GLOBE NEWSWIRE) — The Center for Immigration studies has published m...

January 6, 2023, 8:39 pm

Feds barkin:us central banks more gradual interest rate paths should limit harm to economy

  • Central banks more gradual interest rate path should limit harm to the economy
  • it makes sense for Fed to steer more deliberately on ra...

    January 6, 2023, 5:19 pm

Gbp/usd: extended sideways mode looks for fresh direction signals

Cable remains in extended sideways mode and moving around 200DMA (1.2023), with psychological 1.20 support still offering solid support and holding th...

January 5, 2023, 10:57 am

Okyo pharma eyes progress for ok-101 in 2023, releases interim results

OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO) has released its interim results for the six months ended 30 September 2022, a period in which its primary foc...

December 30, 2022, 4:48 am

Eur/gbp: bulls expected to resume after extended consolidation

The cross firmed on Thursday after Wednesday’s close in red but continues to face headwinds at 0.8850 barrier (50% retracement of 0.9498/0.8202), as...

December 29, 2022, 3:22 pm

Eur/usd: larger bulls to remain in play above broken pivotal fibo barrier

The Euro trades in an extended directionless, narrow-range mode, but underlying bullish structure remains intact, as bulls broke and holding above piv...

December 29, 2022, 10:24 am

Wti oil hits three-week high on improved sentiment

The WTI oil price rose above $80 per barrel and hit the highest level in three weeks on Tuesday, as the latest easing of Covid restriction on China im...

December 27, 2022, 1:33 pm

Bellus health: building momentum around calm, soothe studies

Refractory chronic cough remains as a complex condition that requires a medical breakthrough for treatment. BELLUS Health Inc. is pushing ahead on thi...

December 23, 2022, 12:56 pm

Okyo pharma receives us fda license to start phase 2 study

OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO) said its dry eye disease treatment has received its investigational new drug (IND) application from the US Fo...

December 22, 2022, 2:57 am


Search within

Pages Search Results: